Pharmaceuticals
Drugmakers Have No Magic Pill for Today, but They Do Inject Some Hope
Here's a play in Pfizer.
2 Stocks That Should Perform Well Even if Consumers Pull In Their Horns
There are reasons to be optimistic about Hims & Hers Health and OptiNose Inc.
Ascendis Pharma Presents a Mixed Technical Picture Ahead of Earnings
The biopharmaceutical company could offer a buying opportunity on a pullback based on its chart.
Can Rhythm Pharmaceuticals Keep Up This Tempo?
The stock has surged amid an analyst upgrade.
Lilly Disappoints All Around But Here's When I Would Invest
This stock is in a technical state of weakness and add that to the eroding fundamentals.
Regeneron's 'Regeneration' May Not Last Long
Here's why we see risk for renewed declines in the weeks ahead.
Allogene Therapeutics' Charts Suggests a Rally Ahead
Here's how traders can play the stock.
Merck Continues to Look Like a Slow but Steady Long Bet
It appears buyers of the pharmaceutical giant have been more aggressive than sellers for a while.
Incyte's Setup Should Inspire Bullish Traders
Buyers of the biopharmaceutical's stock are being more aggressive than sellers.
Jazz Pharmaceuticals Is Trading on an Up Note
Here's how we'd play the long side of the biopharmaceutical company.